{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:32:14Z","timestamp":1791484334601,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,3,13]]},"DOI":"10.1212\/wnl.56.5.599","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:51:52Z","timestamp":1336917112000},"page":"599-604","source":"Crossref","is-referenced-by-count":126,"title":["Baclofen treatment in Tourette  syndrome"],"prefix":"10.1212","volume":"56","author":[{"given":"Harvey S.","family":"Singer","sequence":"first","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wendlandt","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Krieger","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Giuliano","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","unstructured":"Singer   HS.   Tourette syndrome and its associated neurobehavioral problems.  In:  Swaiman  K Shields  D eds.  Pediatric neurology: principles and practice 2nd ed.   Baltimore:   CV Mosby;   1999:  598\u2013605."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410210313"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810280040006"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.5.621"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(05)70318-2"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307389901400508"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250308"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307389601100202"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073896011001S05"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198907000-00015"},{"key":"e_1_3_2_12_2","unstructured":"Leckman   JF Tobin   KE Ort   SI et al.  Clinical assessment of tic disorder severity.  In:  Cohen  DJ Bruun  RD Leckman  JF eds.  Tourette\u2019s syndrome and tic disorders.   New York:   John Wiley and Sons;   1988:  55\u201378."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.61.3.506"},{"key":"e_1_3_2_14_2","first-page":"279","volume":"3","year":"1977","unstructured":"Gonce M, Barbeau A. Seven cases of Gilles de la Tourette\u2019s syndrome: partial relief with clonazepam. A pilot study. Can J Neurol Sci . 1977; 3: 279\u2013283.","journal-title":"A pilot study. Can J Neurol Sci"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Merikangas JR Merikangas Kr Kopp U et al. Blood choline and response to clonazepam and haloperidol in Tourette\u2019s syndrome. Acta Psychiatr Scand 1985;72:395\u2013399.","DOI":"10.1111\/j.1600-0447.1985.tb02628.x"},{"key":"e_1_3_2_16_2","first-page":"245","volume":"58","year":"1992","unstructured":"Goetz CG. Clonidine and clonazepam in Tourette syndrome. Review. Adv Neurol . 1992; 58: 245\u2013251.","journal-title":"Review. Adv Neurol"},{"key":"e_1_3_2_17_2","first-page":"341","volume":"72","year":"1985","unstructured":"Mondrup K, Dupont E, Braendgaard H. Progabide in the treatment of hyperkinetic extrapyramidal movement disorders. Acta Neurol Scand . 1985; 72: 341\u2013343.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_18_2","unstructured":"Shapiro   AK Shapiro   ES Young   JG et al.  Gilles de la Tourette syndrome.   2nd ed.   New York:   Raven Press;   1988."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(99)01413-3"},{"key":"e_1_3_2_20_2","unstructured":"Waxham   MN.   Neurotransmitter receptors.  In:  Zigmund  MJ Bloom  FE Landis  SC Roberts  JL Squire  LR eds.  Fundamental neuroscience.   San Diego:   Academic Press;   1999:  235\u2013267."},{"key":"e_1_3_2_21_2","unstructured":"Cooper   JR Bloom   FE Roth   RH.   The biochemical basis of neuropharmacology.   7th ed.   New York:   Oxford University Press;   1996."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1999.00481.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-11-04609.1999"},{"key":"e_1_3_2_24_2","first-page":"195","volume":"9","year":"1998","unstructured":"Shoaib M, Swanner LS, Beyer CE, et al. The GABAB agonist baclofen modifies cocaine self administration in rats. Behav Pharmacol . 1998; 9: 195\u2013206.","journal-title":"Behav Pharmacol"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.3.425"},{"key":"e_1_3_2_26_2","first-page":"391","volume":"35","year":"1982","unstructured":"Leckman JF, Cohen DJ, Detlor J, et al. Clonidine in the treatment of Tourette syndrome: a review of data. Adv Neurol . 1982; 35: 391\u2013401.","journal-title":"Adv Neurol"},{"key":"e_1_3_2_27_2","first-page":"342","volume":"35","year":"1985","unstructured":"Leckman JF, Detlor J, Harcherik D, et al. Short- and long-term treatment of Tourette\u2019s syndrome with clonidine: a clinical perspective. Neurology . 1985; 35: 342\u2013351.","journal-title":"Neurology"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(88)80062-9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.1.14"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(00)00131-4"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00254.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810080052006"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199808000-00013"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.56.5.599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:32:55Z","timestamp":1711643575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.56.5.599"}},"subtitle":["A double-blind, placebo-controlled, crossover trial"],"short-title":[],"issued":{"date-parts":[[2001,3,13]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,3,13]]}},"alternative-id":["10.1212\/WNL.56.5.599"],"URL":"https:\/\/doi.org\/10.1212\/wnl.56.5.599","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,13]]}}}